Skip to content

Clinical study for miR-21 in elderly hypertensive patients with cardiorenal injury

Clinical study for miR-21 in elderly hypertensive patients with cardiorenal injury

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026699
Enrollment
Unknown
Registered
2019-10-19
Start date
2019-10-18
Completion date
Unknown
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

elderly hypertensive patients

Interventions

Hypertension:no

Sponsors

Hebei General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 65 years, gender unlimited; 2. Primary hypertension, grade 1 and above; 3. Hypertension course of 1 year and above.

Exclusion criteria

Exclusion criteria: 1. Cardiac insufficiency and renal insufficiency; 2. Patients with diabetes, gout, primary valvular heart disease, arrhythmia and acute coronary syndrome.

Design outcomes

Primary

MeasureTime frame
miR-21;

Countries

China

Contacts

Public ContactYan Wang

Hebei General Hospital

wy890125fgp@163.com+86 15369350125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026